CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

Original Research2019 Jan 15;139(3):334-336.

JOURNAL:Circulation. Article Link

The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents

Bangalore S. Keywords: biodegradable plastics; clinical trial; drug-eluting stents; polymers; stents

FULL TEXT PDF

网站资料更新中...